VACCELERATE (European Corona Vaccine Trial Accelerator Platform)

VACCELERATE, a 3-year pan-European project, funded by the European Union’s Horizon 2020 Research and Innovation Programme, will accelerate phase 2 & 3 COVID-19 vaccine trials. VACCELERATE brings together the different stakeholders involved in vaccine development across the continent to develop a platform for trial design and conduct.

VACCELERATE will include capacity mapping to identify suitable sites as well as capacity building through the creation of dedicated training. Volunteer registries and access to laboratory sites are also provided within the framework of the project. The project will also ensure the harmonisation of data collection, open data sharing and pooling of data for more robust analysis and data standardisation.

The network once developed for the COVID-19 pandemic can then serve to address new emerging infectious diseases and play a pivotal role in the vaccine development capacities of Europe.

VACCELERATE has received funding from the European Union's Horizon 2020 programme under grant agreement number 101037867.

Project news